Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares.

| More on:
a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With most brokers taking a break over the holiday period, research notes are few and far between right now.

But don't worry! Listed below are three recent broker buy recommendations that still have plenty of upside potential.

Here's why brokers think these ASX shares are in the buy zone:

Pilbara Minerals Ltd (ASX: PLS)

According to a note from Bell Potter, its analysts upgraded this lithium miner's shares to a buy rating with a $2.95 price target.

The broker made the move for a couple of key reasons. The first was on valuation grounds believing that a sharp pullback in its share price has created a buying opportunity for investors. Especially now that short interest in the lithium miner is falling.

Another key reason to invest, according to Bell Potter, is the improving outlook for lithium. Its analysts believe that there could be lithium supply deficits from 2026, which would be a huge boost to prices.

And with Pilbara Minerals having a very strong balance sheet, Bell Potter feels that it is well-placed to respond. The Pilbara Minerals share price is trading at $2.24 this morning.

Pro Medicus Limited (ASX: PME)

A note from Goldman Sachs revealed that its analysts retained their buy rating on this health imaging technology company's shares with an improved price target of $278.00.

The broker believes that Pro Medicus is one of Australia's best global growth companies. This is based partly on its belief that further Visage 7 adoption is a matter of when not if. Goldman is forecasting a strong increase in the value and cadence of contract wins over time.

And while it acknowledges that Pro Medicus' shares are not cheap, trading on 114x FY26E EV/EBITDA, the broker feels that this premium is justified due to its revenue/margin outlook, unique cloud offering, and significant long-term opportunity. The Pro Medicus share price is fetching $250.14 on Friday.

Super Retail Group Ltd (ASX: SUL)

Analysts at Morgans retained their add rating on this retail group's shares with a trimmed price target of $18.55. This followed the release of a first-quarter update from the BCF, Rebel, Macpac, and Supercheap Auto owner.

Morgans notes that the update was a touch softer than expected. This has led to its analysts trimming their earnings forecasts to reflect the challenging trading conditions in the auto parts industry.

Nevertheless, the broker remains positive on its outlook and sees plenty of value on offer with its shares. In addition, Morgans expects Super Retail's shares to offer 6%+ fully franked dividend yields in the near term. The Super Retail share price is trading at $15.34 today.

Motley Fool contributor James Mickleboro has positions in Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and Super Retail Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Super Retail Group. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Broker Notes

These ASX 200 shares could rise 20% and 50% in 2025

Analysts are tipping these shares to beat the market this year. Let's see why.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

More of the best ASX stocks to buy in 2025 according to Bell Potter

Let's see why its analysts are so bullish on these stocks this year.

Read more »

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Broker Notes

Goldman Sachs says these ASX 200 shares are buys

Let's see what the broker is saying about these big names.

Read more »

group of friends jump on the beach
Broker Notes

6 ASX All Ords shares lifted to 'strong buy' consensus ratings for the new year

Brokers upgraded these ASX stocks last month.

Read more »

Broker Notes

Why these ASX 200 stocks could be strong buys in January

Let's see why analysts are bullish on these stocks and are tipping them as buys in January.

Read more »

a man clasps his hand to his forehead as he looks down at his phone and grimaces with a pained expression on his face as he watches the Pilbara Minerals share price continue to fall
Broker Notes

Down 50% and 70%: Why these ASX 200 shares could be cheap buys

Although the S&P/ASX 200 Index (ASX: XJO) has been trading within sight of a record high, the same cannot be said…

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these stocks.

Read more »